Docket Number: FDA-1996-D-0405 Issued by:
Guidance Issuing Office
Office of Regulatory Affairs
Compliance Policy Guide Sec. 110.100 was withdrawn November 4, 2021
Issued: 10/01/1980
Revised: 04/14/2000
Withdrawn: 11/4/2021
Submit Comments
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document’s docket number: FDA-1996-D-0405.
-
Content current as of:
11/04/2021
-
Regulated Product(s)
Topic(s)
